156 related articles for article (PubMed ID: 30299242)
1. Inflammation and cardiovascular disease in familial Mediterranean fever. An analysis of hospital admissions for acute cardiovascular event.
Roitman A; Ben-Zvi I; Mendel L; Livneh A
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):80-85. PubMed ID: 30299242
[TBL] [Abstract][Full Text] [Related]
2. Normal arterial stiffness in familial Mediterranean fever. Evidence for a possible cardiovascular protective role of colchicine.
Kukuy O; Livneh A; Mendel L; Benor A; Giat E; Perski O; Feld O; Kassel Y; Ben-Zvi I; Lidar M; Holtzman EJ; Leiba A
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):32-37. PubMed ID: 28229824
[TBL] [Abstract][Full Text] [Related]
3. A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy.
Bonfrate L; Scaccianoce G; Palasciano G; Ben-Chetrit E; Portincasa P
Eur J Clin Invest; 2017 Sep; 47(9):622-629. PubMed ID: 28678379
[TBL] [Abstract][Full Text] [Related]
4. Behçet's disease and familial Mediterranean fever: Two sides of the same coin or just an association? A cross-sectional study.
Watad A; Tiosano S; Yahav D; Comaneshter D; Shoenfeld Y; Cohen AD; Amital H
Eur J Intern Med; 2017 Apr; 39():75-78. PubMed ID: 27776949
[TBL] [Abstract][Full Text] [Related]
5. Cardiac disease in familial Mediterranean fever.
Erken E; Erken E
Rheumatol Int; 2018 Jan; 38(1):51-58. PubMed ID: 29051974
[TBL] [Abstract][Full Text] [Related]
6. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.
Duzova A; Bakkaloglu A; Besbas N; Topaloglu R; Ozen S; Ozaltin F; Bassoy Y; Yilmaz E
Clin Exp Rheumatol; 2003; 21(4):509-14. PubMed ID: 12942707
[TBL] [Abstract][Full Text] [Related]
7. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
Sante; 2004; 14(4):261-6. PubMed ID: 15745878
[TBL] [Abstract][Full Text] [Related]
8. Non-response to colchicine in familial Mediterranean fever should be identified accurately.
Melikoglu MA; Senel K
Int J Rheum Dis; 2017 Dec; 20(12):2118-2121. PubMed ID: 24702830
[TBL] [Abstract][Full Text] [Related]
9. Behçet's disease in Familial Mediterranean fever: characterization of the association between the two diseases.
Schwartz T; Langevitz P; Zemer D; Gazit E; Pras M; Livneh A
Semin Arthritis Rheum; 2000 Apr; 29(5):286-95. PubMed ID: 10805353
[TBL] [Abstract][Full Text] [Related]
10. Familial Mediterranean fever: an association with non-alcoholic fatty liver disease.
Rimar D; Rosner I; Rozenbaum M; Zuckerman E
Clin Rheumatol; 2011 Jul; 30(7):987-91. PubMed ID: 21360101
[TBL] [Abstract][Full Text] [Related]
11. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
Bilgen SA; Kilic L; Akdogan A; Kiraz S; Kalyoncu U; Karadag O; Ertenli I; Dogan I; Calguneri M
J Clin Rheumatol; 2011 Oct; 17(7):358-62. PubMed ID: 21946459
[TBL] [Abstract][Full Text] [Related]
12. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
[TBL] [Abstract][Full Text] [Related]
13. The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever.
Yoldaş TÇ; Çakar N; Başaran Ö; Acar B; Uncu N; Çaycı FŞ
Clin Rheumatol; 2016 Jun; 35(6):1603-7. PubMed ID: 26384820
[TBL] [Abstract][Full Text] [Related]
14. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in adult patients with Familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence.
Giese A; Kurucay M; Kilic L; Örnek A; Şendur SN; Lainka E; Henning BF
Rheumatol Int; 2013 Jul; 33(7):1713-9. PubMed ID: 23274441
[TBL] [Abstract][Full Text] [Related]
16. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
[TBL] [Abstract][Full Text] [Related]
17. Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increase.
Knieper AM; Klotsche J; Lainka E; Berger T; Dressler F; Jansson AF; Rietschel C; Oommen PT; Berendes R; Niehues T; Neudorf U; Foell D; Wittkowski H; Kallinich T
Rheumatology (Oxford); 2017 Sep; 56(9):1597-1606. PubMed ID: 28859329
[TBL] [Abstract][Full Text] [Related]
18. Semen analysis in adolescents with familial Mediterranean fever.
Kaya Aksoy G; Koyun M; Usta MF; Çomak E; Akman S
J Pediatr Urol; 2019 Aug; 15(4):342.e1-342.e7. PubMed ID: 31036478
[TBL] [Abstract][Full Text] [Related]
19. Assessment of sleep problems in children with familial Mediterranean fever.
Makay B; Kiliçaslan SK; Anik A; Bora E; Bozkaya Ö; Çankaya T; Ünsal E
Int J Rheum Dis; 2017 Dec; 20(12):2106-2112. PubMed ID: 24641439
[TBL] [Abstract][Full Text] [Related]
20. Current trends in colchicine treatment in familial Mediterranean fever.
La Regina M; Ben-Chetrit E; Gasparyan AY; Livneh A; Ozdogan H; Manna R
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):41-6. PubMed ID: 24064013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
